Yuyu Pharmaceutical CEO Robert Yu (second from left) presented the poster study for YP-P10, its new dry eye syndrome treatment, at the 2022 ARVO conference, held in Denver, Col., from Sunday to Wednesday. ARVO, established in 1928, is the world's largest ophthalmology society and has 12,...
Learn about PROSE Treatment for dry eye and other conditions at the Cornea and Laser Eye Institute in New Jersey.
In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has shown it to be a safe, well-tolerated, and effective treatment for dry eye.1 This device offers a new option for managing a condition that affects millions of patie...
" said Dr. Kara Fedders, O.D., the practice's resident dry eye specialist. "The ZEST treatment is a breakthrough that addresses both the symptoms and the causes of dry eye, which are often overlooked. I'm thrilled to bring this effective new option to our...
according to an agreed standard, using objective criteria for clinical and basic research studies.Results There have been tremendous advances in the treatment of dry eye and ocular surface disease in the last decades related to the increase in knowledge regarding the pathophysiology of dry eye. This...
Cequa was assessed in a phase 3 confirmatory study involving 744 patients with dry eye who were treated with Cequa or its vehicle. After 12 weeks of treatment, Cequa led to a statistically significant improvement in the primary endpoint, Schirmer's score (a measurement of tear production;P< ....
1.First, your eye doctor will use the LipiScan imagingdevice to examine your Meibomian glands. This will help your doctor make a diagnosis, which may involve additional testing. 2.If it’s determined that you do have MGD, you can proceed with receiving the 12-minute LipiFlowtreatment.Befor...
and eye care treatments. Lumenis has successfully introduced solutions for previously untreatable conditions and designed advanced technologies that have revolutionized existing treatment methods. We are BeautyTech pioneers, empowering people by broadening the horizons of health and c...
Talley Rostov, MD, cornea, cataract and refractive surgeon at Northwest Eye Surgeons, spoke with Ocular Surgery News about updated medical and surgical treatments for dry eye disease and blepharitis. – by Alaina TedescoReference: Rostov ART. Update on the medical and surgical management of...
The scoop: Joining a crowded dry eye disease market, Bausch + Lomb and Novaliq’s Miebo is the first treatment to directly target tear evaporation, targeting what Bausch + Lomb CEO Brent Saunders has called a “significant unmet need.” Dry eye disease impacts millions of people...